ECLIPSE FILTER SYSTEM - JUGULAR
Report
- Report Number
- 2020394-2021-01129
- Event Type
- Death
- Date Received
- May 28, 2021
- Date of Event
- August 17, 2018
- Report Date
- May 19, 2021
- Manufacturer
- BARD PERIPHERAL VASCULAR, INC.
- Product Code
- DTK
- PMA / PMN Number
- K093659
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AZ, US
- Reporter Occupation
- 003
Narratives
MANUFACTURING REVIEW: A MANUFACTURING REVIEW WAS NOT REQUESTED AS THE LOT NUMBER REPORTED AS UNKNOWN. INVESTIGATION SUMMARY: THE DEVICE WAS NOT RETURNED FOR EVALUATION. MEDICAL RECORDS WERE PROVIDED AND REVIEWED. APPROXIMATELY SIX YEARS AND FOUR MONTHS LATER, THE PATIENT REPORTEDLY EXPIRED BECAUSE OF CARDIAC ARREST, PULMONARY EMBOLISM, AND DEEP VEIN THROMBOSIS. THEREFORE THE INVESTIGATION IS INCONCLUSIVE FOR THE ALLEGED FAILURE AS NO OBJECTIVE EVIDENCE HAS BEEN PROVIDED TO CONFIRM ANY ALLEGED DEFICIENCY WITH THE FILTER. ADDITIONALLY, IT CAN BE CONFIRMED THAT THE PATIENT EXPERIENCED PULMONARY EMBOLISM POST DEPLOYMENT. HOWEVER, THE RELATIONSHIP TO THE FILTER IS UNKNOWN. THE DEFINITIVE ROOT CAUSE COULD NOT BE DETERMINED BASED UPON AVAILABLE INFORMATION. LABELING REVIEW: THE REVIEW OF THE INSTRUCTIONS FOR USE, INDICATIONS, WARNINGS, PRECAUTIONS, CAUTIONS, POSSIBLE COMPLICATIONS, AND CONTRAINDICATIONS SHOWED THAT THE PRODUCT LABELING IS ADEQUATE.
IT WAS REPORTED THROUGH THE LITIGATION PROCESS THAT A VENA CAVA FILTER WAS PLACED IN A PATIENT AFTER BEING DIAGNOSED WITH DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM. AT SOME TIME, POST FILTER DEPLOYMENT, THE PATIENT EXPIRED DUE TO PULMONARY EMBOLISM. THE DEVICE HAS NOT BEEN REMOVED AND THERE WERE NO REPORTED ATTEMPTS MADE TO RETRIEVE THE FILTER. THE PATIENT REPORTEDLY EXPIRED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 797077 | ECLIPSE FILTER SYSTEM - JUGULAR | VENA CAVA FILTER | DTK | BARD PERIPHERAL VASCULAR, INC. | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 41 YR | Death| L |